Disturbed intracortical excitability in early Parkinson's disease is l-DOPA dose related: A prospective 12-month paired TMS study

Parkinsonism and Related Disorders

Volumn 13, Issue 8, 2007, Pages 489-494

  Bareš, Martin ^a   Kaňovský, Petr ^a   Rektor, Ivan ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Basal ganglia; Intracortical facilitation; Intracortical inhibition; l DOPA; Motor cortex; Paired transcranial magnetic stimulation; Parkinson's disease

Indexed keywords

AMANTADINE; BIPERIDEN; LEVODOPA; SELEGILINE;

ADULT; AGED; AKINESIA; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRACRANIAL PRESSURE; MALE; MOTOR CORTEX; NERVE EXCITABILITY; NEUROPHYSIOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION; TREMOR;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; FEMALE; FOLLOW-UP STUDIES; FUNCTIONAL LATERALITY; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PROSPECTIVE STUDIES; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 36049041625     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.02.008     Document Type: Article

References (35)

1. Ziemann U. Intracortical inhibition and facilitation in the conventional paired TMS paradigm. In: Paulus W, Hallett M, Rossini PM, editors. Transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol 1999;(suppl 51):127-36.
2. Modugno N., Curra A., Gilio F., Lorenzano C., Bagnato S., and Berardelli A. Transcranial magnetic stimulation in movement disorders. In: Hallett M., and Chokroverty S. (Eds). Magnetic stimulation in clinical neurophysiology (2005), Elsevier, Amsterdam 181-195
3. Ziemann U. TMS and drugs. Clin Neurophysiol 115 (2004) 1717-1729
4. Berardelli A., Rona S., Inghilleri M., and Manfredi M. Cortical inhibition in Parkinson's disease-a study with paired magnetic stimulation. Brain 119 (1996) 71-77
5. Ridding M.C., Inzelberg R., and Rothwell J.C. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 37 (1995) 181-188
6. Strafella A.P., Valzania F., Nassetti S.A., Tropeani A., Bisulli A., Santangelo M., et al. Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study. Clin Neurophysiol 111 (2000) 1198-1202
7. Cantello R. Applications of transcranial magnetic stimulation in movement disorders. J Clin Neurophysiol 19 (2002) 272-293
8. Curra A., Modugno N., Inghilleri M., Manfredi M., Hallett M., and Berardelli A. Transcranial magnetic stimulation techniques in clinical investigation. Neurology 59 (2002) 1851-1859
9. Valls-Sole J. Neurophysiological characterization of parkinsonian syndromes. Neurophysiol Clin 30 (2000) 352-367
10. Valls-Sole J., and Vallderiola F. Neurophysiological correlate of clinical signs in Parkinson's disease. Clin Neurophysiol 113 (2002) 792-805
11. Chen R., Kumar S., Garg R.R., and Lang A.E. Impairment of motor cortex activation and deactivation in Parkinson's disease. Clin Neurophysiol 112 (2001) 600-607
12. Lewis G.N., and Byblow W.D. Altered sensorimotor integration in Parkinson's disease. Brain 125 (2002) 2089-2099
13. Chen R. Interactions between inhibitory and excitatory circuits in the human motor cortex. Exp Brain Res 154 (2004) 1-10
14. Lefaucher J.P. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation. Clin Neurophysiol 116 (2005) 244-253
15. Bareš M., Kaňovský P., Rektor I., and Hortová H. Intracortical inhibition and facilitation are impaired in early Parkinson's disease patients-a paired TMS study. Eur J Neurol 10 (2003) 385-389
16. Ziemann U., Tergau F., Bruns D., Baudewig J., and Paulus W. Changes in human motor cortex excitability induces by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol 105 (1997) 430-437
17. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., et al. Corticocortical inhibition in human motor cortex. J Physiol 471 (1993) 501-519
18. Buhmann C., Gorsler A., Baumer T., Hidding U., Demiralay C., Hinkelmann K., et al. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease. Brain 127 (2004) 2732-2746
19. Mir P., Matsunaga K., Gilio F., Quinn N.P., Siebner H.R., and Rothwell J.C. Dopaminergic drugs restore facilitatory premotor-motor interactions in Parkinson disease. Neurology 64 (2005) 1906-1912
20. Ziemann U., Bruns D., and Paulus W. Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation. Neurosci Lett 208 (1996) 187-190
21. Pierantozzi M., Palmieri M.G., Marciani M.G., Bernardi G., Giacomini P., and Stanzione P. Effect of apomorphine on cortical inhibition in Parkinson′s disease patients: a transcranial magnetic stimulation study. Exp Brain Res 141 (2001) 52-62
22. Maeda F., Gangitano M., Thall M., and Pascual-Leone A. Inter- and intra-individual variability of paired-pulse curves with transcranial magnetic stimulation (TMS). Clin Neurophysiol 113 (2002) 376-382
23. Bagnato S., Agostino R., Modugno N., Quartarone A., and Berardelli A. Plasticity of the motor cortex in Parkinson's disease patients on and off therapy. Mov Disord 21 (2006) 639-645
24. Nitsche M.A., Lampe C., Antal A., Liebetanz D., Lang N., Tergau F., et al. Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex. Eur J Neurosci 23 (2006) 1651-1657
25. Pierantozzi M., Palmieri M.G., Mazzone P., Marciani M.G., Rossini P.M., Stefani A., et al. Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study. Clin Neurophysiol 113 (2002) 108-113
26. Ueki Y., Mima T., Kotb M.A., Sawada H., Saiki H., Ikeda A., et al. Altered plasticity of the human motor cortex in Parkinson's disease. Ann Neurol 59 (2006) 60-71
27. Muellbacher E., Ziemann U., Boroojerdi B., Cohen L., and Hallett M. Role of the human motor cortex in rapid motor learning. Exp Brain Res 136 (2001) 431-438
28. Bareš M., and Rektor I. Basal ganglia involvement in cognitive and sensory processing. A SEEG CNV study in human subjects. Clin Neurophysiol 112 (2001) 2022-2030
29. Bareš M., Rektor I., Kaňovský P., and Streitová H. Cortical and subcortical distribution of sensory and cognitive operations. A contingent negative variation SEEG study. Clin Neurophysiol 114 (2003) 2447-2460
30. Garcia L., Audin J., D' Alessandro G., Bioulac B., and Hammond C. Dual effect of high-frequency stimulation on subthalamic neuron activity. J Neurosci 23 (2003) 8743-8751
31. Silberstein P., Pogosyan A., Kühn A.A., Hotton G., Tisch S., Kupsch A., et al. Cortico-cortical coupling in Parkinson's disease and its modulation by therapy. Brain 128 (2005) 1277-1291
32. Lefaucher J.P. Motor cortex stimulation for Parkinson's disease and dystonia: lessons from transcranial magnetic stimulation? A review of the literature. Rev Neurol 161 (2005) 27-41
33. Cohen L.G., Ziemann U., Chen R., Classen J., Hallett M., Gerloff C., et al. Studies of neuroplasticity with transcranial magnetic stimulation. J Clin Neurophysiol 15 (1998) 305-324
34. Cunic D., Roshan L., Khan F.I., Lozano A.M., Lang A.E., and Chen R. Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's disease. Neurology 58 (2002) 1665-1672
35. Kobayashi M., and Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol 2 (2003) 145-156